Product category

Other Pharmaceutical API (4)

Showing 1–4 of 4 products · Page 1 of 1

Hyaluronidase
Other Pharmaceutical API

Hyaluronidase

CAS 9001-54-1

Brand names of animal-derived hyaluronidase include HydaseTM (developed and manufactured by PrimaPharm Inc., distributed by Akorn Inc.), which has been FDA-approved as a "thimerosal-free" animal-derived hyaluronidase, Vitrase (ISTA Pharmaceuticals), Amphadase (Amphastar Pharmaceuticals), and Wydase. Wydase, however, is no longer manufactured.By catalyzing the hydrolysis of hyaluronan, a constituent of the extracellular matrix (ECM), hyaluronidase lowers the viscosity of hyaluronan, thereby increasing tissue permeability. It is, therefore, used in medicine in conjunction with other medicine to speed their dispersion and delivery. Common applications are ophthalmic surgery, in combination with local anesthetics. It also increases the absorption rate of parenteral fluids given byhypodermoclysis, and is an adjunct in subcutaneous urography for improving resorption of radiopaque agents. Hyaluronidase is also used for extravasation of hyperosmolar solutions.

Lidocaine
Other Pharmaceutical API

Lidocaine

CAS 137-58-6

Lidocaine is a first-line drug for the treatment of ventricular arrhythmias caused by acute and severe hemodynamic abnormalities. For some supraventricular arrhythmias, such as bypass-mediated supraventricular tachycardia and acute onset or parasympathetic nerve-mediated cardioversion of atrial fibrillation is also effective. It is widely used for mucosal surface anesthesia (such as before tracheal intubation).

Nicergoline
Other Pharmaceutical API

Nicergoline

CAS 27848-84-6

1-methyl-lumilysergol8-(5-bromonicotinate)10-methylether

Pimecrolimus
Other Pharmaceutical API

Pimecrolimus

CAS 137071-32-0

Pimecrolimus is a topical immunomodulators and is a kind of semi-synthetic products of the Streptomyces-produced ascomycin. It has a greater lipophilicity than tacrolimus with a stronger affinity with the skin. It can effectively and safely control the signs and symptoms of facial seborrheic dermatitis and can quickly relieve the itching symptoms of patients with dermatitis and eczema as well as reduce the lesion area, clear atopic dermatitis (eczema) sign. Therefore, it is an effective treatment method for the treatment of atopic dermatitis (eczema) for both early remission purpose and long-term control purpose.

×
MOSINTER chemical operations

Request a Quote

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

MOSINTER GROUP